Varenicline to reduce smoking in Veterans not ready to quit
About this title
Read the official source — NCT06966362Understand this study
Who could participate?
Listed age limits: from 21 years.
What will I do during this study?
Participants who smoke are assigned to medication options for a smoking-reduction phase, then may enter a quit phase. The study also includes brief counseling calls: five calls during the motivation phase and, for those who enter cessation treatment, four more calls.
- Listed locations
- San Diego and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 400
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT06966362
- Official title
Show the full official title
Varenicline for Smoking Reduction in Veterans Unwilling to Quit
Recruitment & locations
San Diego · Minneapolis · Durham
1 more locations
- Madison
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge and Cessation-Phase Varenicline.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as recruiting.
